J E Squires1,2, D Stacey1,2, M Coughlin1, M Greenough2, A Roberts3,4, K Dorrance1, M Clemons5,6,7,8, J M Caudrelier9, I D Graham1,8, J Zhang10,11, M Demery Varin2, A Arnaout3,4,5. 1. Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON. 2. School of Nursing, Faculty of Health Sciences, University of Ottawa, Ottawa, ON. 3. Breast Surgical Oncology Unit, The Ottawa Hospital, Ottawa, ON. 4. Department of Surgery, Faculty of Medicine, University of Ottawa, Ottawa, ON. 5. Cancer Therapeutics Program, The Ottawa Hospital Research Institute, Ottawa, ON. 6. Department of Medicine, University of Ottawa, Ottawa, ON. 7. Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON. 8. Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, ON. 9. Department of Radiation Medicine, The Ottawa Hospital, Ottawa, ON. 10. Division of Plastic and Reconstructive Surgery, University of Ottawa, Ottawa, ON. 11. Department of Plastic Surgery, The Ottawa Hospital, Ottawa, ON.
Abstract
Background: Rates of contralateral prophylactic mastectomy (cpm) continue to rise internationally despite evidence-based guidance strongly discouraging its use in most women with unilateral breast cancer. The purpose of the present study was to develop and assess the feasibility of a knowledge translation tool [a patient decision aid (da)] designed to enhance evidence-informed shared decision-making about cpm. Methods: A consultation da was developed using the Ottawa Patient Decision Aid Development eTraining in consultation with clinicians and knowledge translation experts. The final da was then assessed for feasibility with health care professionals and patients across Canada. The assessment involved a survey completed online (health care professionals) or by telephone (patients). Survey data were analyzed using descriptive statistics for closed-ended questions and qualitative content analysis for open-ended questions. Results: The 51 participants who completed the survey included 39 health care professionals and 12 patients. The da was acceptable; 88% of participants viewed it as having the right amount of information or slightly more or less information than they would like. Almost all participants (98%) felt that the da would prepare patients to make better decisions. The aid was perceived to be usable, with 73% of participants stating that they would be willing to use or share the da. Conclusions: The cpm patient da developed for the present study was viewed by health care professionals and patients across Canada to be acceptable and usable during the clinical consultation. It holds promise as a knowledge translation tool to be used by clinicians in consultation with women who have unilateral breast cancer to enhance evidence-informed and shared decision-making with respect to undergoing cpm.
Background: Rates of contralateral prophylactic mastectomy (cpm) continue to rise internationally despite evidence-based guidance strongly discouraging its use in most women with unilateral breast cancer. The purpose of the present study was to develop and assess the feasibility of a knowledge translation tool [a patient decision aid (da)] designed to enhance evidence-informed shared decision-making about cpm. Methods: A consultation da was developed using the Ottawa Patient Decision Aid Development eTraining in consultation with clinicians and knowledge translation experts. The final da was then assessed for feasibility with health care professionals and patients across Canada. The assessment involved a survey completed online (health care professionals) or by telephone (patients). Survey data were analyzed using descriptive statistics for closed-ended questions and qualitative content analysis for open-ended questions. Results: The 51 participants who completed the survey included 39 health care professionals and 12 patients. The da was acceptable; 88% of participants viewed it as having the right amount of information or slightly more or less information than they would like. Almost all participants (98%) felt that the da would prepare patients to make better decisions. The aid was perceived to be usable, with 73% of participants stating that they would be willing to use or share the da. Conclusions: The cpm patient da developed for the present study was viewed by health care professionals and patients across Canada to be acceptable and usable during the clinical consultation. It holds promise as a knowledge translation tool to be used by clinicians in consultation with women who have unilateral breast cancer to enhance evidence-informed and shared decision-making with respect to undergoing cpm.
Entities:
Keywords:
Contralateral prophylactic mastectomy; decision aids; evidence-informed care; shared decision-making; unilateral breast cancer
Authors: Trudy van der Weijden; Heleen Post; Paul L P Brand; Haske van Veenendaal; Ton Drenthen; Linda Aj van Mierlo; Peep Stalmeier; Olga C Damman; Anne Stiggelbout Journal: Z Evid Fortbild Qual Gesundhwes Date: 2017-05-19
Authors: France Légaré; Stéphane Ratté; Dawn Stacey; Jennifer Kryworuchko; Karine Gravel; Ian D Graham; Stéphane Turcotte Journal: Cochrane Database Syst Rev Date: 2010-05-12
Authors: Dawn Stacey; Carol L Bennett; Michael J Barry; Nananda F Col; Karen B Eden; Margaret Holmes-Rovner; Hilary Llewellyn-Thomas; Anne Lyddiatt; France Légaré; Richard Thomson Journal: Cochrane Database Syst Rev Date: 2011-10-05
Authors: J E Squires; S N Simard; S Asad; D Stacey; I D Graham; M Coughlin; M Clemons; J M Grimshaw; J Zhang; J M Caudrelier; A Arnaout Journal: Curr Oncol Date: 2019-08-01 Impact factor: 3.677